Saks Samuel R

CIK 00013656158 companiesBURLINGAME, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001365615

Recent Transactions

50 trades

Award
Protagonist Therapeutics, Inc$PTGX
Common Stock
2021-02-26+12,000→ 14,000 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2021-02-26+90,000→ 90,000 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2020-02-28+85,000→ 85,000 total
Award
PDL BIOPHARMA, INC.
Stock Option (right to buy)
2019-06-20$3.00/sh+126,050→ 126,050 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2019-05-15+45,000→ 45,000 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2019-02-28+15,000→ 15,000 total
Award
Protagonist Therapeutics, Inc$PTGX
Common Stock
2019-02-28+2,500→ 2,500 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2018-06-12+20,000→ 20,000 total
Award
PDL BIOPHARMA, INC.
Common stock
2018-06-08$2.76/sh+54,348→ 214,190 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2018-05-31+50,000→ 50,000 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2017-06-20+20,000→ 20,000 total
Award
PDL BIOPHARMA, INC.
Common stock
2017-06-09$2.47/sh+60,729→ 159,842 total
Exercise/Conversion
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, $0.001 par value
2017-05-27+750→ 6,605 total
Exercise/Conversion
Tonix Pharmaceuticals Holding Corp.$TNXP
Restricted Stock Units
2017-05-27−750→ 0 total
Exercise/Conversion
Tonix Pharmaceuticals Holding Corp.$TNXP
Restricted Stock Units
2017-02-09−750→ 0 total
Exercise/Conversion
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, $0.001 par value
2017-02-09+750→ 5,855 total
Purchase
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, $0.001 par value
2016-06-21$2.00/sh+12,500→ 51,050 total
Purchase
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, $0.001 par value
2016-06-21$2.00/sh+25,000→ 63,550 total
Award
PDL BIOPHARMA, INC.
Common stock
2016-06-02$3.52/sh+71,023→ 99,113 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Restricted Stock Unit
2016-05-27+7,500→ 7,500 total
Award
Assertio Therapeutics, Inc
Stock Options
2016-05-18+7,669→ 7,669 total
Award
Assertio Therapeutics, Inc
Restricted Stock Units
2016-05-18+3,131→ 3,131 total
Tax Payment
Assertio Therapeutics, Inc
Common Stock
2016-05-12$17.52/sh−734→ 5,099 total
Exercise/Conversion
Tonix Pharmaceuticals Holding Corp.$TNXP
Restricted Stock Units
2016-02-25−650→ 0 total
Exercise/Conversion
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, $0.001 par value
2016-02-25+600→ 3,855 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Restricted Stock Unit
2016-02-09+7,500→ 7,500 total
Tax Payment
Assertio Therapeutics, Inc
Common Stock
2015-12-01$19.00/sh−966→ 2,897 total
Award
PDL BIOPHARMA, INC.
Common stock
2015-09-14$5.34/sh+28,090→ 28,090 total
Purchase
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, $0.001 par value
2015-07-17$7.50/sh+10,000→ 32,550 total
Award
Assertio Therapeutics, Inc
Stock Option
2015-05-12+7,857→ 7,857 total
Award
Assertio Therapeutics, Inc
Restricted Stock Unit
2015-05-12+2,936→ 2,936 total
Disposition from Tender
Auspex Pharmaceuticals, Inc.
Common Stock
2015-05-05−67,338→ 0 total
Disposition to Issuer
Auspex Pharmaceuticals, Inc.
Employee Stock Option (Right to Buy)
2015-05-05−47,777→ 0 total
Disposition to Issuer
Auspex Pharmaceuticals, Inc.
Employee Stock Option (Right to Buy)
2015-05-05−27,235→ 0 total
Disposition to Issuer
Auspex Pharmaceuticals, Inc.
Employee Stock Option (Right to Buy)
2015-05-05−7,777→ 0 total
Disposition to Issuer
Auspex Pharmaceuticals, Inc.
Employee Stock Option (Right to Buy)
2015-05-05−30,000→ 0 total
Disposition to Issuer
Auspex Pharmaceuticals, Inc.
Restricted Stock Units
2015-05-05−15,000→ 0 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2015-02-25+5,000→ 5,000 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Restricted Stock Unit
2015-02-25+6,000→ 6,000 total
Award
Auspex Pharmaceuticals, Inc.
Restricted Stock Units
2015-02-02+15,000→ 15,000 total
Award
Auspex Pharmaceuticals, Inc.
Stock Option (right to buy)
2015-02-02+30,000→ 30,000 total
Award
Assertio Therapeutics, Inc
Stock Option
2014-12-01+9,852→ 9,852 total
Award
Assertio Therapeutics, Inc
Restricted Stock Unit
2014-12-01+3,863→ 3,863 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2014-10-29+5,000→ 5,000 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2014-02-11+5,500→ 5,500 total
Purchase
Auspex Pharmaceuticals, Inc.
Common Stock
2014-02-10$12.00/sh+2,175→ 63,839 total
Award
Assertio Therapeutics, Inc
Stock Option
2013-12-10+20,000→ 20,000 total
Purchase
Tonix Pharmaceuticals Holding Corp.$TNXP
Series A common stock purchase warrant
2013-08-14+5,883→ 5,883 total
Purchase
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, $0.001 par value
2013-08-14+5,883→ 22,550 total
Conversion
Tonix Pharmaceuticals Holding Corp.$TNXP
Warrants
2013-04-26−166,667→ 166,667 total

Companies

Recent Filings

Address

2404 HILLSIDE DRIVE

BURLINGAME, CA, 94010

View on SEC.gov